Serum levels of natriuretic peptides in patients with Behcet's disease

Clinical Rheumatology

Volumn 27, Issue 9, 2008, Pages 1153-1158

  Yaǧi, Ramazan ^a,d   Totan, Yüksel ^a   Özlük, Ekin ^b   Özyurt, Hüseyin ^c   Akbay, Gülfer ^b   Ekşioğlu, Meral ^b  

^a FATIH UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c GAZIOSMANPASA UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Behcet's disease; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C;

ADULT; ARTICLE; BEHCET DISEASE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; VASCULITIS;

EID: 48449085870     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-0886-0     Document Type: Article

References (49)

1. Barnes CG, Yazici H (1999) Behcet's syndrome. Rheumatology (Oxford) 38:1171-1174
2. Nakao K, Isashiki Y, Sonoda S et al (2007) Nitric oxide synthase and superoxide dismutase gene polymorphisms in Behcet disease. Arch Ophthalmol 125:246-251
3. Sakane T, Takeno M, Suzuki N et al (1999) Behcet's disease. N Engl J Med 341:1284-1291
4. Yazici H, Yurdakul S, Hamuryudan V (2001) Behcet disease. Curr Opin Rheumatol 13:18-22
5. Cekmen M, Evereklioglu C, Er H et al (2003) Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behcet's syndrome. Int J Dermatol 42:870-875
6. Er H, Evereklioglu C, Cumurcu T et al (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease. Br J Ophthalmol 86:653-657
7. Yapislar H, Aydogan S, Borlu M et al (2007) Decreased nitric oxide and increased platelet aggregation levels in patients with Behcet's disease. Thromb Res 119:461-465
8. Ahluwalia A, MacAllister RJ, Hobbs AJ (2004) Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms. Basic Res Cardiol 99:83-89
9. Wang TJ, Larson MG, Levy D et al (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655-663
10. Sohne M, Ten Wolde M, Boomsma F et al (2006) Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. J Thromb Haemost 4:552-556
11. Akar H, Konuralp C, Akpolat T (2003) Cardiovascular involvement in Behcet's disease. Anadolu Kardiyol Derg 3:261-265
12. International Study Group for Behcet's D (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080
13. Lawton G, Bhakta BB, Chamberlain MA et al (2004) The Behcet's disease activity index. Rheumatology (Oxford) 43:73-78
14. Hamuryudan V, Fresko I, Direskeneli H et al (1999) Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome. Rheumatology (Oxford) 38:734-736
15. Porstmann T, Kiessig ST (1992) Enzyme immunoassay techniques. An overview. J Immunol Methods 150:5-21
16. Avrameas S (1992) Amplification systems in immunoenzymatic techniques. J Immunol Methods 150:23-32
17. Lu Y, Ye P, Chen SL et al (2005) Identification of kinectin as a novel Behcet's disease autoantigen. Arthritis Res Ther 7:R1133-R1139
18. Xiang Y, Sekine T, Nakamura H et al (2004) Proteomic surveillance of autoimmunity in osteoarthritis: Identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum 50:1511-1521
19. Okunuki Y, Usui Y, Takeuchi M et al (2007) Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: Selenium binding protein is a novel autoantigen in Behcet's disease. Exp Eye Res 84:823-831
20. Lee KH, Chung HS, Kim HS et al (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum 48:2025-2035
21. Evereklioglu C, Yurekli M, Er H et al (2000) Increased plasma adrenomedullin levels in patients with Behcet's disease. Dermatology 201:312-315
22. Yazici C, Kose K, Calis M et al (2004) Increased advanced oxidation protein products in Behcet's disease: A new activity marker? Br J Dermatol 151:105-111
23. Isik A, Koca SS, Ustundag B et al (2007) Decreased total antioxidant response and increased oxidative stress in Behcet's disease. Tohoku J Exp Med 212:133-141
24. Taysi S, Demircan B, Akdeniz N et al (2007) Oxidant/antioxidant status in men with Behcet's disease. Clin Rheumatol 26:418-422
25. Sepici-Dincel A, Ozkan Y, Yardim-Akaydin S et al (2006) The association between total antioxidant status and oxidative stress in Behcet's disease. Rheumat Int 26:1005-1009
26. Bekpinar S, Kilic N, Unlucerci Y et al (2005) Evaluation of nitrosative and oxidative stress in Behcet disease. J Eur Acad Dermatol Venereol 19:167-171
27. Kiemer AK, Vollmar AM (2001) The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages. Ann Rheum Dis 60(Suppl 3):iIi68-70
28. Vollmar AM (2005) The role of atrial natriuretic peptide in the immune system. Peptides 26:1086-1094
29. Kiemer AK, Vollmar AM (1998) Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J Biol Chem 273:13444-13451
30. Aiura K, Ueda M, Endo M et al (1995) Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat. Crit Care Med 23:1898-1906
31. Roques BP (1998) Cell surface metallopeptidases involved in blood pressure regulation: Structure, inhibition and clinical perspectives. Pathol Biol (Paris) 46:191-200
32. Soleilhac JM, Lucas E, Beaumont A et al (1992) A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium. Mol Pharmacol 41:609-614
33. Maack T, Suzuki M, Almeida FA et al (1987) Physiological role of silent receptors of atrial natriuretic factor. Science 238:675-678
34. Maack T (1992) Receptors of atrial natriuretic factor. Annu Rev Physiol 54:11-27
35. Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A et al (2001) Neutrophil activation in Behcet's disease. Clin Exp Rheumatol 19:S19-24
36. McKie PM, Burnett JC Jr (2005) B-type natriuretic peptide as a biomarker beyond heart failure: Speculations and opportunities. Mayo Clin Proc 80:1029-1036
37. Nakamura M, Endo H, Nasu M et al (2002) Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 87:131-135
38. Kiely DG, Kennedy NS, Pirzada O et al (2005) Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respir Med 99:1286-1291
39. Scotland RS, Ahluwalia A, Hobbs AJ (2005) C-type natriuretic peptide in vascular physiology and disease. Pharmacol Ther 105:85-93
40. Wright RS, Wei CM, Kim CH et al (1996) C-type natriuretic peptide-mediated coronary vasodilation: Role of the coronary nitric oxide and particulate guanylate cyclase systems. J Am Coll Cardiol 28:1031-1038
41. Hussain MB, MacAllister RJ, Hobbs AJ (2001) Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases. Am J Physiol Heart Circ Physiol 280:H1151-1159
42. Madhani M, Scotland RS, MacAllister RJ et al (2003) Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol 139:1289-1296
43. Orem A, Vanizor B, Cimsit G et al (1999) Decreased nitric oxide production in patients with Behcet's disease. Dermatology 198:33-36
44. Mirza GE, Karakucuk S, Er M et al (2001) Tear nitrite and nitrate levels as nitric oxide end products in patients with Behcet's disease and non-Behcet's uveitis. Ophthalmic Res 33:48-51
45. Sahin M, Arslan C, Naziroglu M et al (2006) Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease. Ann Clin Lab Sci 36:449-454
46. Buldanlioglu S, Turkmen S, Ayabakan HB et al (2005) Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet's disease. Br J Dermatol 153:526-530
47. Ozkan Y, Yardim-Akaydin S, Sepici A et al (2007) Assessment of homocysteine, neopterin and nitric oxide levels in Behcet's disease. Clin Chem Lab Med 45:73-77
48. Chauhan SD, Hobbs AJ, Ahluwalia A (2004) C-type natriuretic peptide: New candidate for endothelium-derived hyperpolarising factor. Int J Biochem Cell Biol 36:1878-1881
49. Ohno N, Itoh H, Ikeda T et al (2002) Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation 105:1623-1626